Become a Member
News

DNA tests for breast cancer gene mutation affecting Ashkenazi Jews can lead to unnecessary surgery

Around one in every 400 people in the general population carries a faulty BRCA1 or BRCA2 gene, but the risk factor for people of Ashkenazi Jewish descent is 10 times greater

September 15, 2023 14:40
Angelina Jolie
US actress Angelina Jolie arrives for the State Dinner in honor of South Korean President Yoon Suk Yeol, at the White House in Washington, DC, on April 26, 2023. (Photo by Stefani Reynolds / AFP) (Photo by STEFANI REYNOLDS/AFP via Getty Images)
1 min read

Some women are undergoing unnecessary mastectomies after taking private DNA tests that show they carry mutated genes that increase the likelihood of developing breast cancer, research suggests.

These gene mutations disproportionately affect Ashkenazi Jews, with around one in 40 people of Ashkenazi Jewish descent carrying a faulty BRCA1 or BRCA2 gene, compared with around one in 400 people in the general population.

Most cases of breast and ovarian cancer are not due to a genetic fault, but where testing does detect this mutation, clinicians can recommend breast or ovary removal surgery as a preventative measure.

Until recently, women who learned they carried a heightened risk did so because they attended a clinic due to symptoms or a family history of disease. However, many people now pay for at-home DNA testing kits, or are given their results after taking part in genetic research, and have not had any personal link with breast cancer, according to a new study.